Cytosorbents Corp

OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA

Cytosorbents Faces Nasdaq Compliance and Delisting Risk - TipRanks

Cytosorbents Faces Nasdaq Compliance and Delisting Risk TipRanks

Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow - Seeking Alpha

Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow Seeking Alpha

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing

CytoSorbents schedules two FDA pre-submission meetings for ticagrelor and DOAC programs - TradingView

CytoSorbents schedules two FDA pre-submission meetings for ticagrelor and DOAC programs TradingView

CTSO: Strong sales, high margins, and advancing FDA approvals position for growth in critical care - TradingView

CTSO: Strong sales, high margins, and advancing FDA approvals position for growth in critical care TradingView